Articles

Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid® efficacy and long-term safety study

Department of Hematology “L. e A. Seragnoli”, St Orsola-Malpighi Hospital, Bologna, Italy
Department of Hematology, Hospital del Mar-IMIM, Barcelona, Spain
Hematology and Oncology, Johannes Wesling Klinikum Minden, Germany
Department of Hematology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
AP-HP, Hôpital Saint-Louis, Centre d’Investigations Cliniques, Paris, France
Shire Pharmaceuticals Ltd., Basingstoke, UK
Shire Pharmaceuticals Ltd., Basingstoke, UK
Former employee of Shire Pharmaceuticals Ltd., Basingstoke, UK
Department of Hematology, Uppsala University, Sweden
Vol. 99 No. 4 (2014): April, 2014 https://doi.org/10.3324/haematol.2012.083097